Review




Structured Review

STEMCELL Technologies Inc rosettesep method
Rosettesep Method, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rosettesep method/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
rosettesep method - by Bioz Stars, 2026-05
90/100 stars

Images



Similar Products

90
STEMCELL Technologies Inc rosettesep method
Rosettesep Method, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rosettesep method/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
rosettesep method - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc rosettesep nk-cell enrichment mixture method
Rosettesep Nk Cell Enrichment Mixture Method, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rosettesep nk-cell enrichment mixture method/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
rosettesep nk-cell enrichment mixture method - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc rosettesep circulating tumor cell enrichment method
Rosettesep Circulating Tumor Cell Enrichment Method, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rosettesep circulating tumor cell enrichment method/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
rosettesep circulating tumor cell enrichment method - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc rosettesep nk-cell enrichment mixture method kit
Rosettesep Nk Cell Enrichment Mixture Method Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rosettesep nk-cell enrichment mixture method kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
rosettesep nk-cell enrichment mixture method kit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc rosettesep nk cell enrichment mixture method
Inhibition of ERAP1 enhances <t>NK</t> <t>cell</t> killing of 221-B*51:01 cells. (A) , Example of degranulation by human CD56 + <t>NK</t> <t>cells</t> from one healthy donor expressing KIR2DL1, KIR2DL3, and KIR3DL1 measured as CD107a cell surface expression in response to the indicated cells. The percentage of CD107a + cells within the indicated NK cell subsets is shown. (B) Summary of NK cell degranulation from donors after stimulation with 221 parental and transfectant cells in response to ERAP1 inhibition. P values, calculated by two-tailed paired Student’s t -test. ns, not significant.
Rosettesep Nk Cell Enrichment Mixture Method, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rosettesep nk cell enrichment mixture method/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
rosettesep nk cell enrichment mixture method - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc rosettesep method 15216
Inhibition of ERAP1 enhances <t>NK</t> <t>cell</t> killing of 221-B*51:01 cells. (A) , Example of degranulation by human CD56 + <t>NK</t> <t>cells</t> from one healthy donor expressing KIR2DL1, KIR2DL3, and KIR3DL1 measured as CD107a cell surface expression in response to the indicated cells. The percentage of CD107a + cells within the indicated NK cell subsets is shown. (B) Summary of NK cell degranulation from donors after stimulation with 221 parental and transfectant cells in response to ERAP1 inhibition. P values, calculated by two-tailed paired Student’s t -test. ns, not significant.
Rosettesep Method 15216, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rosettesep method 15216/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
rosettesep method 15216 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Inhibition of ERAP1 enhances NK cell killing of 221-B*51:01 cells. (A) , Example of degranulation by human CD56 + NK cells from one healthy donor expressing KIR2DL1, KIR2DL3, and KIR3DL1 measured as CD107a cell surface expression in response to the indicated cells. The percentage of CD107a + cells within the indicated NK cell subsets is shown. (B) Summary of NK cell degranulation from donors after stimulation with 221 parental and transfectant cells in response to ERAP1 inhibition. P values, calculated by two-tailed paired Student’s t -test. ns, not significant.

Journal: Frontiers in Immunology

Article Title: ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

doi: 10.3389/fimmu.2021.778103

Figure Lengend Snippet: Inhibition of ERAP1 enhances NK cell killing of 221-B*51:01 cells. (A) , Example of degranulation by human CD56 + NK cells from one healthy donor expressing KIR2DL1, KIR2DL3, and KIR3DL1 measured as CD107a cell surface expression in response to the indicated cells. The percentage of CD107a + cells within the indicated NK cell subsets is shown. (B) Summary of NK cell degranulation from donors after stimulation with 221 parental and transfectant cells in response to ERAP1 inhibition. P values, calculated by two-tailed paired Student’s t -test. ns, not significant.

Article Snippet: Human NK cells were isolated from peripheral blood mononuclear cells (PBMC) of healthy donors co-expressing KIR2DL1, KIR2DL2 and KIR3DL1 by using the RosetteSep NK cell enrichment mixture method (Stem-Cell Technologies).

Techniques: Inhibition, Expressing, Transfection, Two Tailed Test

Inhibition of ERAP1 enhanced NK cell killing of 221-B*51:01 cells by affecting the engagement of KIR3DL1. (A) , Example of degranulation by human CD56 + NK cells from one healthy donor co-expressing KIR2DL1, KIR2DL3, and KIR3DL1; CD107a cell surface expression was measured in specific KIR single positive (KIRsp) subsets (KIR3DL1sp for 221-B51 cells, KIR2DL1sp for 221-Cw4 cells and KIR2DL3 for 221-Cw3 and -Cw7 cells) in response to ERAP1-inhibited 221 transfectants and control cells. The percentage of CD107a + cells within the indicated NK cell subsets is shown. (B) , Summary of NK cell degranulation in the indicated KIRsp NK subsets from healthy donors after stimulation with 221 parental and transfectant cells in response to ERAP1 inhibition. P values, calculated by two-tailed paired Student’s t -test. ns, not significant.

Journal: Frontiers in Immunology

Article Title: ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

doi: 10.3389/fimmu.2021.778103

Figure Lengend Snippet: Inhibition of ERAP1 enhanced NK cell killing of 221-B*51:01 cells by affecting the engagement of KIR3DL1. (A) , Example of degranulation by human CD56 + NK cells from one healthy donor co-expressing KIR2DL1, KIR2DL3, and KIR3DL1; CD107a cell surface expression was measured in specific KIR single positive (KIRsp) subsets (KIR3DL1sp for 221-B51 cells, KIR2DL1sp for 221-Cw4 cells and KIR2DL3 for 221-Cw3 and -Cw7 cells) in response to ERAP1-inhibited 221 transfectants and control cells. The percentage of CD107a + cells within the indicated NK cell subsets is shown. (B) , Summary of NK cell degranulation in the indicated KIRsp NK subsets from healthy donors after stimulation with 221 parental and transfectant cells in response to ERAP1 inhibition. P values, calculated by two-tailed paired Student’s t -test. ns, not significant.

Article Snippet: Human NK cells were isolated from peripheral blood mononuclear cells (PBMC) of healthy donors co-expressing KIR2DL1, KIR2DL2 and KIR3DL1 by using the RosetteSep NK cell enrichment mixture method (Stem-Cell Technologies).

Techniques: Inhibition, Expressing, Control, Transfection, Two Tailed Test

Inhibition of ERAP1 enhanced NK cell killing of 221-B*51:01 cells by affecting the engagement of NKG2A. (A) , Example of degranulation by human CD56 + NK cells from one healthy donor; CD107a cell surface expression was measured in NKG2A positive subset negative for KIR3DL1, KIR2DL1 and KIR2DL3 in response to ERAP1-inhibited 221 transfectants and control cells. The percentage of CD107a + cells within the indicated NK cell subset is shown. (B) , Summary of NK cell degranulation in the NKG2A positive KIR negative NK subset from healthy donors after stimulation with 221 parental and transfectant cells in response to ERAP1 inhibition. P values, calculated by two-tailed paired Student’s t -test. ns, not significant.

Journal: Frontiers in Immunology

Article Title: ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

doi: 10.3389/fimmu.2021.778103

Figure Lengend Snippet: Inhibition of ERAP1 enhanced NK cell killing of 221-B*51:01 cells by affecting the engagement of NKG2A. (A) , Example of degranulation by human CD56 + NK cells from one healthy donor; CD107a cell surface expression was measured in NKG2A positive subset negative for KIR3DL1, KIR2DL1 and KIR2DL3 in response to ERAP1-inhibited 221 transfectants and control cells. The percentage of CD107a + cells within the indicated NK cell subset is shown. (B) , Summary of NK cell degranulation in the NKG2A positive KIR negative NK subset from healthy donors after stimulation with 221 parental and transfectant cells in response to ERAP1 inhibition. P values, calculated by two-tailed paired Student’s t -test. ns, not significant.

Article Snippet: Human NK cells were isolated from peripheral blood mononuclear cells (PBMC) of healthy donors co-expressing KIR2DL1, KIR2DL2 and KIR3DL1 by using the RosetteSep NK cell enrichment mixture method (Stem-Cell Technologies).

Techniques: Inhibition, Expressing, Control, Transfection, Two Tailed Test

Genetical and pharmacological inhibition of ERAP1 makes 221-B*51:01 cells more susceptible to lysis by NK cells expressing KIR3DL1*001. (A, B) 221 transfectant cells genetically (A) or pharmacologically (B) inhibited for ERAP1 were incubated with YTS or YTS-KIR3DL1*001 NK cells. A representative experiment of three independently performed is shown. Data represented mean ± SD of triplicate.

Journal: Frontiers in Immunology

Article Title: ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

doi: 10.3389/fimmu.2021.778103

Figure Lengend Snippet: Genetical and pharmacological inhibition of ERAP1 makes 221-B*51:01 cells more susceptible to lysis by NK cells expressing KIR3DL1*001. (A, B) 221 transfectant cells genetically (A) or pharmacologically (B) inhibited for ERAP1 were incubated with YTS or YTS-KIR3DL1*001 NK cells. A representative experiment of three independently performed is shown. Data represented mean ± SD of triplicate.

Article Snippet: Human NK cells were isolated from peripheral blood mononuclear cells (PBMC) of healthy donors co-expressing KIR2DL1, KIR2DL2 and KIR3DL1 by using the RosetteSep NK cell enrichment mixture method (Stem-Cell Technologies).

Techniques: Inhibition, Lysis, Expressing, Transfection, Incubation